1. Homepage
  2. Equities
  3. Mexico
  4. Mexican Stock Exchange
  5. Genomma Lab Internacional, S.A.B. de C.V.
  6. Company
    LAB B   MX01LA010006

GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.

(LAB B)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Genomma Lab Internacional SAB de CV is a Mexico-based over-the-counter pharmaceutical (OTC pharmaceutical), generic drugs (GD) and personal care products company. The Company is engaged in the development, distribution and marketing of a range of products within different brands, for such treatments as anti-acne, varicose vein, hair loss, sexual stimulation and influenza; as well as analgesics and antifungals. The Company’s product portfolio includes such brands as Asepxia, Cicatricure, Goicoechea, Bengue, Diabet TX, Genoprazol, Goicotabs, Shot B, SilkaMedic, Siluet 40, Nikzon, X Ray, Next, Touch Me, Lomecan V and QG5, among others. The Company is a parent of a number of controlled entities, which have operations established in Mexico, the United States, Peru, Chile, Ecuador and Honduras, among others. In June 2014, the Company acquired 50% stake in Grupo Comercial e Industrial Marzam SA de CV.

Number of employees : 2 221 people.
Sales per Business
20202021Delta
Pharmaceutical Products and Personal Care Products13 870.10100%15 487.10100% +11.66%
MXN in Million
Sales per region
20202021Delta
International7 866.0256.7%9 023.5158.3% +14.72%
Mexico6 004.1343.3%6 463.5541.7% +7.65%
MXN in Million
Managers
Name Title Age Since
Jorge Luis Brake Valderrama Chief Executive Officer - 2018
Antonio Zamora Galland Vice President-Administration & Finance - -
Marco Sparvieri Chief Operating Officer & Executive Vice President - -
Alejandro Bastón Patiño EVP-Media & Institutional Affairs - -
Members of the board
Name Title Age Since
Rodrigo Alonso Herrera Aspra Chairman - -
Juan Alonso Independent Director - -
Juan Carlos Gavito Aspe Independent Director - -
Jorge Ricardo Gutiérrez Muñoz Independent Director 77 -
Javier Vale Castilla Independent Director - -
Ignacio Gonzalez Rodriguez Independent Director - -
Burkhard Wittek, Dr. Independent Director 68 2018
Carlos Javier Vara Alonso Independent Director - 2018
Sabrina Lucila Herrera Aspra Director - -
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,048,000,000 743,241,600 70.9% 37,988,578 3.6% 70.9%
Shareholders
NameEquities%
Rodrigo Alonso Herrera Aspra 304,758,400 29.1%
Massachusetts Financial Services Co. 56,800,324 5.42%
Fidelity Management & Research Co. LLC 50,622,369 4.83%
Norges Bank Investment Management 43,851,302 4.18%
AllianceBernstein LP 31,945,400 3.05%
Capital Research & Management Co. (World Investors) 23,292,475 2.22%
The Vanguard Group, Inc. 22,957,841 2.19%
BlackRock Fund Advisors 14,833,837 1.42%
BlackRock México SA de CV Asesor en Inversiones Independiente 13,683,835 1.31%
Dimensional Fund Advisors LP 10,584,976 1.01%
Company contact information
Genomma Lab Internacional SAB de CV
Avendia Antonio Dovalí Jaime, 70
Torre C, Piso 2, Despacho A
Col. Santa Fe, Del. Álvaro Obregnó
Mexico City, Distrito Federal 01210

Phone : +52.55.5081.0000
Fax : +52.55.5081.0000
Web : http://www.genommalab.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Genomma Lab Internacional, S.A.B. de C.V.
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.-5.82%1 021
JOHNSON & JOHNSON2.59%461 811
PFIZER, INC.-14.65%282 789
ABBVIE INC.12.58%269 361
ELI LILLY AND COMPANY6.87%265 718
ROCHE HOLDING AG-15.26%264 329
NOVO NORDISK A/S1.07%238 091
MERCK & CO., INC.20.17%232 903
ASTRAZENECA PLC18.05%196 890
NOVARTIS AG8.37%191 223
BRISTOL-MYERS SQUIBB COMPANY23.53%163 981
SANOFI13.93%132 243
AMGEN INC.8.44%130 323
GLAXOSMITHKLINE PLC10.18%111 134
BAYER AG35.74%65 777
DAIICHI SANKYO CO., LTD.13.68%49 715
CHUGAI PHARMACEUTICAL CO., LTD-2.84%46 551
TAKEDA PHARMACEUTICAL COMPANY LIMITED17.63%44 429
ASTELLAS PHARMA INC.6.50%27 985
JIANGSU HENGRUI MEDICINE CO., LTD.-42.32%27 750
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD-33.03%26 513